Global Airway Management Devices Market

Airway Management Devices Market Size, Share, Growth Analysis, By Device(Infraglottic devices, supraglottic devices, laryngoscopes, resuscitators), By End user(Hospitals, ambulatory care, home care, and others), By Patient age(Adult patients and pediatric patients), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2165 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 91 | Figures: 76

Airway Management Devices Market Insights

Airway Management Devices Market size was valued at USD 2 billion in 2022 and is poised to grow from USD 2.32 billion in 2023 to USD 3.62 billion by 2030, at a CAGR of 7.7% during the forecast period (2023-2030).

The rising demand for airway management devices is mostly driven by the rising prevalence of respiratory illnesses and chronic obstructive pulmonary disease (COPD).

According to the World Health Organisation, mild to severe COPD affects 65 million people worldwide, making it the third greatest cause of death worldwide. Additionally, according to information from the Centres for Disease Control and Prevention (CDC), over nine million people in 2018 received a diagnosis of chronic bronchitis.

The rise in the number of operations and the use of anesthesia, both of which require sophisticated technologies, is also blamed for the rise in demand for airway management systems. The necessity for emergency care for chronic illnesses and long-term lung-related therapies for both children and adults are anticipated to further fuel market growth.

The aging population, which is more prone to respiratory diseases, is another factor in the rise in demand for airway control equipment. However, because of poor healthcare insurance programmes, pricey airway control devices are not widely used in developing nations. The World Bank Group estimates that the average cost of healthcare in developing countries is USD 80 per person per year (or USD 0.5 trillion), which has a detrimental effect on the financial status of the poor because universal health coverage is frequently absent.

Players in the market are investing in research and development (R&D) to create clever and distinctive strategies in order to maintain their growth in the market. These tactics include the introduction of new products, mergers and acquisitions, partnerships, collaborations, and the renovation of current technologies.

US Airway Management Devices Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Airway Management Devices Market size was valued at USD 2 billion in 2022 and is poised to grow from USD 2.32 billion in 2023 to USD 3.62 billion by 2030, at a CAGR of 7.7% during the forecast period (2023-2030).

The existence of several major manufacturers competing for a sizable market share defines the competitive landscape of the airway management devices industry. To improve their market position, the businesses concentrate on developing innovative products, forming strategic alliances, and making acquisitions. They make significant investments in R&D to bring forth technologically cutting-edge and user-friendly airway management equipment. The businesses also participate in marketing campaigns and distribution alliances to broaden their reach internationally and boost their clientele. Additionally, new firms are entering the market, which increases competition. 'Medtronic (United States)', 'Smiths Medical (United States)', 'Teleflex Incorporated (United States)', 'Ambu A/S (Denmark)', 'Intersurgical Ltd. (United Kingdom)', 'Vyaire Medical Inc. (United States)', 'Medline Industries, Inc. (United States)', 'Flexicare Medical Limited (United Kingdom)', 'Mercury Medical (United States)', 'SunMed (United States)', 'Armstrong Medical Ltd. (United Kingdom)', 'Salter Labs (United States)', 'VBM Medizintechnik GmbH (Germany)', 'Medisize (Flex Ltd.) (United States)', 'Verathon Inc. (United States)', 'Intlock (Israel)', 'KARL STORZ SE & Co. KG (Germany)', 'UE Medical Devices Pvt. Ltd. (India)', 'Well Lead Medical Co., Ltd. (China)', 'Airways Corporation (India)'

The rising prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, is a significant driver for the airway management devices market. These conditions necessitate the use of airway management devices for effective treatment and management.

In recent years, the market has experienced a number of significant market trends. The demand for sophisticated airway management systems with improved features and functions is one obvious trend. During airway procedures, these gadgets are intended to increase patient safety and deliver better results. The increasing use of video laryngoscopes, which provide better visualization and precision during intubation procedures, is another noteworthy trend. Additionally, due to their simplicity of use, speedy insertion, and low risk of problems, supraglottic airway devices are being used more frequently on the market. To reduce the chance of cross-contamination and guarantee infection control, there is also a move towards disposable airway management tools.

North America dominated the market in 2022 and is projected to remain the fastest growing region during the forecast period, due to the prevalence of asthma and chronic obstructive pulmonary disease, as well as the increase in the elderly population. The U.S. Census Bureau reports that as of 2017, more than 50 million Americans aged 65 and older were at the highest risk of developing chronic conditions. In North America, two important countries where such airway management devices have been widely adopted are the U.S. and Canada. The main causes of the rising need for airway management devices market forecast in North America are the rise in pollution rate and the increase in occurrences of respiratory problems, even in neonatal care. Increase in healthcare R&D spending, and the rising incidence of chronic diseases such as COPD, the U.S. market will experience considerable expansion during the forecast period due to favorable reimbursement policies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Airway Management Devices Market

Report ID: SQMIG35B2165

$5,300
BUY NOW GET FREE SAMPLE